Biote Financial Statements From 2010 to 2026

BTMD Stock

USD 2.49 0.00 0.00%

Biote Corp's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Biote Corp's valuation are provided below:

Gross Profit

141.6 M

Profit Margin

0.1472

Market Capitalization

118.2 M

Enterprise Value Revenue

0.7879

Revenue

195.6 M

There are over one hundred nineteen available fundamental signals for biote Corp, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Biote Corp's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable down the road. The current year's Market Cap is expected to grow to about 200.1 M. The current year's Enterprise Value is expected to grow to about 267.7 M

Biote Corp Total Revenue

167.47 Million

Check Biote Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biote Corp's main balance sheet or income statement drivers, such as Tax Provision of 1.4 M, Depreciation And Amortization of 4.3 M or Interest Expense of 13.3 M, as well as many indicators such as Price To Sales Ratio of 0.51, Dividend Yield of 0.0245 or Days Sales Outstanding of 11.67. Biote financial statements analysis is a perfect complement when working with Biote Corp Valuation or Volatility modules.

Build AI portfolio with Biote Stock

Check out the analysis of Biote Corp Correlation against competitors.

For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.

Biote Corp Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

91.7 M

140.7 M

55.7 M

Slightly volatile

Short and Long Term Debt Total

86.7 M

127.5 M

65.4 M

Slightly volatile

Other Current Liabilities

43.4 M

41.4 M

11.4 M

Slightly volatile

Total Current Liabilities

62.2 M

59.2 M

22.2 M

Slightly volatile

Other Liabilities

44.8 M

42.7 M

12.5 M

Slightly volatile

Property Plant And Equipment Net

12.3 M

11.8 M

4.3 M

Slightly volatile

Net Debt

86.4 M

82.2 M

41.7 M

Slightly volatile

Accounts Payable

4.4 M

6.7 M

3.8 M

Slightly volatile

Cash

48 M

45.2 M

26.5 M

Slightly volatile

Non Current Assets Total

65.5 M

62.4 M

16.7 M

Slightly volatile

Cash And Short Term Investments

48 M

45.2 M

26.5 M

Slightly volatile

Net Receivables

6.7 M

8.9 M

5.2 M

Slightly volatile

Common Stock Shares Outstanding

41.4 M

39.4 M

14.1 M

Slightly volatile

Liabilities And Stockholders Equity

91.7 M

140.7 M

55.7 M

Slightly volatile

Non Current Liabilities Total

111.5 M

199 M

77 M

Slightly volatile

Inventory

11.2 M

17.1 M

7.3 M

Slightly volatile

Other Current Assets

4.7 M

7.2 M

2.7 M

Slightly volatile

Total Liabilities

136.2 M

258.3 M

97 M

Slightly volatile

Total Current Assets

70.7 M

78.3 M

41.7 M

Slightly volatile

Short Term Debt

6.5 M

7.8 M

5.7 M

Slightly volatile

Intangible Assets

11.3 M

10.8 M

3.9 M

Slightly volatile

Property Plant Equipment

3.1 M

4.1 M

3 M

Slightly volatile

Current Deferred Revenue

2.6 M

3.4 M

2.2 M

Slightly volatile

Long Term Debt

85.5 M

116.4 M

56.3 M

Slightly volatile

Capital Lease Obligations

4.1 M

3.9 M

1.3 M

Slightly volatile

Net Invested Capital

1.3 M

1.4 M

27.9 M

Very volatile

Property Plant And Equipment Gross

20.1 M

19.1 M

7.7 M

Slightly volatile

Short and Long Term Debt

6.3 M

7.2 M

5.4 M

Slightly volatile

Net Working Capital

18.1 M

19.1 M

26.1 M

Slightly volatile

Common Stock

3.4 K

3.6 K

224.1 M

Slightly volatile

Non Current Liabilities Other

58.5 M

77.5 M

40.1 M

Slightly volatile

Other Assets

0.8

0.9

0.9824

Slightly volatile

Biote Corp Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Tax Provision

1.4 M

1.1 M

657 K

Slightly volatile

Depreciation And Amortization

4.3 M

4.1 M

1.5 M

Slightly volatile

Interest Expense

13.3 M

12.7 M

4.3 M

Slightly volatile

Selling General Administrative

88.1 M

123.6 M

57.7 M

Slightly volatile

Selling And Marketing Expenses

4.2 M

6.1 M

Slightly volatile

Total Revenue

167.5 M

226.8 M

135.1 M

Slightly volatile

Gross Profit

111 M

159.9 M

86.7 M

Slightly volatile

Other Operating Expenses

151.1 M

190.4 M

114.3 M

Slightly volatile

EBIT

19.5 M

10.8 M

22.8 M

Pretty Stable

EBITDA

20.8 M

14 M

24.1 M

Pretty Stable

Cost Of Revenue

56.4 M

66.8 M

48.4 M

Slightly volatile

Total Operating Expenses

94.6 M

123.6 M

65.9 M

Slightly volatile

Reconciled Depreciation

4.3 M

4.1 M

1.6 M

Slightly volatile

Net Income Applicable To Common Shares

30.5 M

37.5 M

25.9 M

Slightly volatile

Income Tax Expense

844.8 K

1.1 M

435.6 K

Slightly volatile

Biote Corp Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Begin Period Cash Flow

107.5 M

102.4 M

25.7 M

Slightly volatile

Depreciation

2.2 M

4.1 M

1.5 M

Slightly volatile

Dividends Paid

4.1 M

4.3 M

36.8 M

Slightly volatile

Capital Expenditures

7.8 M

7.4 M

2.8 M

Slightly volatile

Net Income

39.3 K

41.4 K

16.4 M

Slightly volatile

End Period Cash Flow

48 M

45.2 M

26.5 M

Slightly volatile

Change To Netincome

30 M

28.6 M

8.4 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

0.51

0.97

0.6782

Very volatile

Dividend Yield

0.0245

0.0258

0.4905

Slightly volatile

Days Sales Outstanding

11.67

12.83

13.6464

Pretty Stable

Stock Based Compensation To Revenue

0.0484

0.0509

0.3923

Slightly volatile

Capex To Depreciation

1.74

2.07

1.8465

Slightly volatile

EV To Sales

0.7

1.29

0.9656

Pretty Stable

Inventory Turnover

7.1

4.5

8.8487

Slightly volatile

Days Of Inventory On Hand

55.6

83.89

50.108

Slightly volatile

Payables Turnover

15.5

16.02

14.0507

Slightly volatile

Sales General And Administrative To Revenue

0.95

0.9

0.4945

Slightly volatile

Capex To Revenue

0.015

0.0293

0.0173

Slightly volatile

Cash Per Share

0.98

1.03

2.1236

Pretty Stable

Days Payables Outstanding

22.58

32.85

27.3646

Pretty Stable

Intangibles To Total Assets

0.0589

0.11

0.0763

Very volatile

Net Debt To EBITDA

4.33

4.13

2.0601

Slightly volatile

Current Ratio

1.13

1.19

1.9954

Slightly volatile

Receivables Turnover

27.64

29.44

26.723

Slightly volatile

Capex Per Share

0.26

0.22

0.2291

Very volatile

Revenue Per Share

6.29

6.62

13.2548

Slightly volatile

Interest Debt Per Share

7.57

4.09

6.5538

Very volatile

Debt To Assets

1.22

1.04

1.5706

Slightly volatile

Enterprise Value Over EBITDA

17.17

16.35

6.845

Slightly volatile

Graham Number

5.81

6.54

7.1362

Slightly volatile

Operating Cycle

67.27

96.72

63.7545

Slightly volatile

Days Of Payables Outstanding

22.58

32.85

27.3646

Pretty Stable

Total Debt To Capitalization

21.23

20.22

6.0356

Slightly volatile

Quick Ratio

0.88

0.93

1.6427

Slightly volatile

Cash Ratio

0.65

0.69

1.2416

Slightly volatile

Cash Conversion Cycle

44.7

63.87

36.3905

Slightly volatile

Days Of Inventory Outstanding

55.6

83.89

50.108

Slightly volatile

Days Of Sales Outstanding

11.67

12.83

13.6464

Pretty Stable

Free Cash Flow Operating Cash Flow Ratio

1.05

0.99

0.9513

Slightly volatile

Fixed Asset Turnover

21.08

22.19

39.5515

Pretty Stable

Enterprise Value Multiple

17.17

16.35

6.845

Slightly volatile

Debt Ratio

1.22

1.04

1.5706

Slightly volatile

Price Sales Ratio

0.51

0.97

0.6782

Very volatile

Asset Turnover

2.75

1.85

3.5916

Slightly volatile

Gross Profit Margin

0.53

0.63

0.6191

Slightly volatile

Biote Corp Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

200.1 M

190.6 M

98.3 M

Slightly volatile

Enterprise Value

267.7 M

255 M

137.9 M

Slightly volatile

Biote Fundamental Market Drivers

	Forward Price Earnings	6.3331
	Cash And Short Term Investments	39.3 M

Biote Upcoming Events

	26th of March 2024 Upcoming Quarterly Report	View
	14th of May 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	26th of March 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Biote Corp Financial Statements

Biote Corp stakeholders use historical fundamental indicators, such as Biote Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Biote Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Biote Corp's assets and liabilities are reflected in the revenues and expenses on Biote Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in biote Corp. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Current Deferred Revenue	3.4 M	2.6 M
Total Revenue	226.8 M	167.5 M
Cost Of Revenue	66.8 M	56.4 M
Stock Based Compensation To Revenue	0.05	0.05
Sales General And Administrative To Revenue	0.90	0.95
Capex To Revenue	0.03	0.02
Revenue Per Share	6.62	6.29
Ebit Per Revenue	0.18	0.12

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

JBL	Jabil Circuit
MRK	Merck Company
AMGN	Amgen Inc

When determining whether biote Corp is a strong investment it is important to analyze Biote Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Biote Corp's future performance. For an informed investment choice regarding Biote Stock, refer to the following important reports:

How To Invest In Biote

Details

Is Biote Stock a good investment?

Details

What is Biote Corp's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of Biote Corp Correlation against competitors.

For information on how to trade Biote Stock refer to our How to Trade Biote Stock guide.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biote Corp. If investors know Biote will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biote Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.33)

Earnings Share

0.79

Revenue Per Share

5.937

Quarterly Revenue Growth

(0.07)

Return On Assets

0.2195

The market value of biote Corp is measured differently than its book value, which is the value of Biote that is recorded on the company's balance sheet. Investors also form their own opinion of Biote Corp's value that differs from its market value or its book value, called intrinsic value, which is Biote Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biote Corp's market value can be influenced by many factors that don't directly affect Biote Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Biote Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biote Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biote Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Biote Financial Statements From 2010 to 2026

Biote Corp Total Revenue

167.47 Million

Biote Corp Balance Sheet

Biote Corp Income Statement

Biote Corp Cash Flow Statement

Financial Ratios

Biote Corp Valuation Data

Biote Fundamental Market Drivers

Biote Upcoming Events

About Biote Corp Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY